v3.26.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2026
Segment Information [Abstract]  
Schedule of Significant Segment Expenses

The following table summarized significant segment expenses for the three months and six months ended June 30, 2026 and 2025:

 

    Lysosomal Storage Disorders Segment  
    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2026     2025     2026     2025  
    (In thousands)  
Research and development expenses (excluding stock compensation)   $ (719 )   $ (476 )   $ (1,398 )   $ (848 )
General and administrative expenses (excluding stock compensation)     (661 )     (300 )     (1,473 )     (528 )
Stock-based compensation           (108 )     (467 )     (4,560 )
Other expense – direct listing offering costs           (124 )     (586 )     (124 )
Net loss   $ (1,380 )   $ (1,008 )   $ (3,924 )   $ (6,060 )